File Download
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1136/gut.52.4.502
- Scopus: eid_2-s2.0-0037537477
- PMID: 12631658
- WOS: WOS:000181828100010
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Promoter methylation of E-cadherin gene in gastric mucosa associated with Helicobacter pylori infection and in gastric cancer
Title | Promoter methylation of E-cadherin gene in gastric mucosa associated with Helicobacter pylori infection and in gastric cancer |
---|---|
Authors | |
Issue Date | 2003 |
Publisher | BMJ Publishing Group. The Journal's web site is located at http://gut.bmjjournals.com/ |
Citation | Gut, 2003, v. 52 n. 4, p. 502-506 How to Cite? |
Abstract | Background: E-cadherin is an adhesion molecule involved in tumour invasion/metastasis. Silencing of E-cadherin by promoter CpG methylation has been shown in both familial and sporadic gastric cancers. Helicobacter pylori is a class I carcinogen in gastric cancer. Aims: This study was undertaken to investigate the association between methylation of E-cadherin and H pylori in gastric mucosa from dyspeptic patients, and in intestinal metaplasia and primary and meta-static adenocarcinoma from surgical specimens of patients with gastric cancer. Methods: E-cadherin methylation was studied using methylation specific polymerase chain reaction in microdissected tissue from biopsies or surgical resection specimens. E-cadherin expression was studied by immunohistochemistry. Results: E-cadherin methylation was present in 31% (11/35) of gastric mucosae from dyspeptic patients, and was associated with H pylori infection (p=0.002), but was independent of the age of the patient or presence or absence of gastritis. E-cadherin methylation was present in 0% (0/8) of normal mucosa, 57% (12/21) of intestinal metaplasias, and 58% (15/26) of primary and 65% (21/32) of metastatic cancers. E-cadherin methylation status was concordant in 92% (11/12) of intestinal metaplasias and primary cancers, and in 85% (17/20) of primary and metastatic cancers from the same resected specimen. E-cadherin methylation in gastric cancer was associated with depth of tumour invasion (p=0.02) and regional nodal metastasis (p=0.05). Conclusion: E-cadherin methylation is an early event in gastric carcinogenesis, and is initiated by H pylori infection. |
Persistent Identifier | http://hdl.handle.net/10722/43098 |
ISSN | 2023 Impact Factor: 23.0 2023 SCImago Journal Rankings: 8.052 |
PubMed Central ID | |
ISI Accession Number ID | |
References |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Chan, AOO | en_HK |
dc.contributor.author | Lam, SK | en_HK |
dc.contributor.author | Wong, BCY | en_HK |
dc.contributor.author | Wong, WM | en_HK |
dc.contributor.author | Yuen, MF | en_HK |
dc.contributor.author | Yeung, YH | en_HK |
dc.contributor.author | Hui, WM | en_HK |
dc.contributor.author | Rashid, A | en_HK |
dc.contributor.author | Kwong, YL | en_HK |
dc.date.accessioned | 2007-03-23T04:38:48Z | - |
dc.date.available | 2007-03-23T04:38:48Z | - |
dc.date.issued | 2003 | en_HK |
dc.identifier.citation | Gut, 2003, v. 52 n. 4, p. 502-506 | en_HK |
dc.identifier.issn | 0017-5749 | en_HK |
dc.identifier.uri | http://hdl.handle.net/10722/43098 | - |
dc.description.abstract | Background: E-cadherin is an adhesion molecule involved in tumour invasion/metastasis. Silencing of E-cadherin by promoter CpG methylation has been shown in both familial and sporadic gastric cancers. Helicobacter pylori is a class I carcinogen in gastric cancer. Aims: This study was undertaken to investigate the association between methylation of E-cadherin and H pylori in gastric mucosa from dyspeptic patients, and in intestinal metaplasia and primary and meta-static adenocarcinoma from surgical specimens of patients with gastric cancer. Methods: E-cadherin methylation was studied using methylation specific polymerase chain reaction in microdissected tissue from biopsies or surgical resection specimens. E-cadherin expression was studied by immunohistochemistry. Results: E-cadherin methylation was present in 31% (11/35) of gastric mucosae from dyspeptic patients, and was associated with H pylori infection (p=0.002), but was independent of the age of the patient or presence or absence of gastritis. E-cadherin methylation was present in 0% (0/8) of normal mucosa, 57% (12/21) of intestinal metaplasias, and 58% (15/26) of primary and 65% (21/32) of metastatic cancers. E-cadherin methylation status was concordant in 92% (11/12) of intestinal metaplasias and primary cancers, and in 85% (17/20) of primary and metastatic cancers from the same resected specimen. E-cadherin methylation in gastric cancer was associated with depth of tumour invasion (p=0.02) and regional nodal metastasis (p=0.05). Conclusion: E-cadherin methylation is an early event in gastric carcinogenesis, and is initiated by H pylori infection. | en_HK |
dc.format.extent | 215201 bytes | - |
dc.format.extent | 28672 bytes | - |
dc.format.mimetype | application/pdf | - |
dc.format.mimetype | application/msword | - |
dc.language | eng | en_HK |
dc.publisher | BMJ Publishing Group. The Journal's web site is located at http://gut.bmjjournals.com/ | en_HK |
dc.relation.ispartof | Gut | en_HK |
dc.rights | Gut. Copyright © B M J Publishing Group. | en_HK |
dc.subject.mesh | Cadherins - genetics - metabolism | en_HK |
dc.subject.mesh | Helicobacter infections - complications - genetics - metabolism | en_HK |
dc.subject.mesh | Helicobacter pylori | en_HK |
dc.subject.mesh | Promoter regions (genetics) - genetics | en_HK |
dc.subject.mesh | Stomach neoplasms - genetics - metabolism - microbiology | en_HK |
dc.title | Promoter methylation of E-cadherin gene in gastric mucosa associated with Helicobacter pylori infection and in gastric cancer | en_HK |
dc.type | Article | en_HK |
dc.identifier.openurl | http://library.hku.hk:4550/resserv?sid=HKU:IR&issn=0017-5749&volume=52&issue=4&spage=502&epage=506&date=2003&atitle=Promoter+methylation+of+E-cadherin+gene+in+gastric+mucosa+associated+with+Helicobacter+pylori+infection+and+in+gastric+cancer | en_HK |
dc.identifier.email | Wong, BCY:bcywong@hku.hk | en_HK |
dc.identifier.email | Yuen, MF:mfyuen@hkucc.hku.hk | en_HK |
dc.identifier.email | Kwong, YL:ylkwong@hku.hk | en_HK |
dc.identifier.authority | Wong, BCY=rp00429 | en_HK |
dc.identifier.authority | Yuen, MF=rp00479 | en_HK |
dc.identifier.authority | Kwong, YL=rp00358 | en_HK |
dc.description.nature | published_or_final_version | en_HK |
dc.identifier.doi | 10.1136/gut.52.4.502 | en_HK |
dc.identifier.pmid | 12631658 | - |
dc.identifier.pmcid | PMC1773595 | - |
dc.identifier.scopus | eid_2-s2.0-0037537477 | en_HK |
dc.identifier.hkuros | 77693 | - |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-0037537477&selection=ref&src=s&origin=recordpage | en_HK |
dc.identifier.volume | 52 | en_HK |
dc.identifier.issue | 4 | en_HK |
dc.identifier.spage | 502 | en_HK |
dc.identifier.epage | 506 | en_HK |
dc.identifier.isi | WOS:000181828100010 | - |
dc.publisher.place | United Kingdom | en_HK |
dc.identifier.scopusauthorid | Chan, AOO=7403167965 | en_HK |
dc.identifier.scopusauthorid | Lam, SK=7402279473 | en_HK |
dc.identifier.scopusauthorid | Wong, BCY=7402023340 | en_HK |
dc.identifier.scopusauthorid | Wong, WM=7403972413 | en_HK |
dc.identifier.scopusauthorid | Yuen, MF=7102031955 | en_HK |
dc.identifier.scopusauthorid | Yeung, YH=7006608758 | en_HK |
dc.identifier.scopusauthorid | Hui, WM=7103196477 | en_HK |
dc.identifier.scopusauthorid | Rashid, A=7102299914 | en_HK |
dc.identifier.scopusauthorid | Kwong, YL=7102818954 | en_HK |
dc.identifier.issnl | 0017-5749 | - |